The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last
20 years and is expected to increase until 2030 in some countries including the United …

Pancreatic cancer is one of the most aggressive malignancies of the digestive tract and
carries a poor prognosis. The majority of patients have advanced disease at the time of …

Background & Aims Epidemiology of hepatocellular carcinoma is changing worldwide. This
study aimed at evaluating the changing scenario of aetiology, presentation, management …

Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan …

Self-expandable metal stents (SEMS) are the current standard of care for the palliative
management of malignant biliary strictures. Recently, endoscopic ablative techniques with …

Introduction Radiofrequency ablation and percutaneous ethanol injection are important
treatment modalities for hepatocellular carcinoma patients; Whether a combination treatment …

Objective Hepatocellular carcinoma (HCC) is the third leading cause of cancer death
worldwide. We conducted network meta-regression within a Bayesian framework to …

Background Hepatocyte nuclear factor-3β (HNF-3β) plays a critical role in hepatocyte
differentiation and controls liver-specific gene expression during the development of …

Hepatocellular carcinoma (HCC) is the most common liver-derived malignancy with a high
fatality rate. Risk factors for the development of HCC have been identified and are clearly …

The morbidity associated with pancreatectomies limits surgical options for high-risk patients
with pancreatic neoplasms that warrant resection. Endoscopic ultrasound-guided …